Narula, Neeraj, and Hasan Hamam. “Selective JAK1 Inhibition Using Upadacitinib for the Management of Inflammatory Bowel Diseases: The Powerful Pill”. Canadian IBD Today 1, no. S11 (November 23, 2023): 2–11. Accessed May 10, 2024. https://canadianibdtoday.com/article/view/1-s11-narula_hamam.